Clinical trial
Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus
NCT04834518 is registered in ClinicalTrials.gov with Rabin Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening for Islet Autoantibodies in the Israeli Paediatric General Population for Detection of Pre-symptomatic Type-1 Diabetes Mellitus
- Lead sponsor
- Rabin Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 1, 2021
- Completion date
- March 31, 2027
- Enrollment
- 50,000 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
type1diabetes